Updated: September 3, 2026 | 12-minute read
Red light therapy is often dismissed as wellness marketing. That view is understandable, but it is too broad.
Does infrared and red light therapy really work? Research suggests possible benefits for some specific applications, but results are not uniform. Red light at 660 nm and near-infrared at 850 nm have been studied in relation to mitochondrial chromophores, including cytochrome c oxidase. Changes in ATP-related measures or cellular signaling do not, by themselves, prove a clinical benefit. Research has examined wound healing, muscle recovery, and localized pain, with results varying by condition, device, and protocol.
The key distinction is between a proposed mechanism, clinical evidence, and a device that matches research conditions. This article explains what the evidence supports and how irradiance, wavelength, exposure time, and distance affect comparison with published studies. It also provides a practical framework for evaluating devices and marketing claims.
What red light therapy actually is — and what it asks of your biology
Red and near-infrared light wavelengths shown across skin layers diagram
What actually happens inside your body when you use red light therapy?
Red light around 660 nm and near-infrared light around 850 nm have been studied in relation to mitochondrial chromophores, including cytochrome c oxidase. One proposed model is that light exposure may affect mitochondrial redox signaling, ATP-related measures, reactive oxygen species, and other cellular pathways. The size and direction of these changes depend on the biological and exposure conditions. Researchers call this area photobiomodulation, but a proposed mechanism does not prove a clinical outcome.
Scientists use "photobiomodulation" to describe light exposure studied with defined optical and biological parameters. The term does not guarantee a particular outcome. When reading research, check the wavelength, irradiance, exposure time, target, and measured outcome. A product labeled "red light therapy" may not reproduce those conditions.
Is red light therapy a hoax, then?
That's a fair question. PBM is a genuine area of biomedical research, but many devices make similar claims without showing comparable output. A different wavelength, irradiance, exposure time, or geometry may produce different results from those reported in a PBM study. This difference is easy to miss and often creates skepticism.
Red light and infrared therapy is marketed for skin aging, joint pain, sleep, and many other goals. This broad marketing naturally invites skepticism. The rest of this article asks what the evidence supports and how to distinguish documented device performance from borrowed research language.
What the science actually says: reading the evidence fairly
Researcher reviewing clinical light therapy trial data with LED panels in the background
Mechanistic evidence and clinical evidence are not the same. Confusing them causes much of the uncertainty about whether infrared and red light therapy really works.
Mechanistic studies examine mitochondrial chromophores, redox signaling, ATP-related measures, and cellular responses. The exact role of each pathway is still being studied. Clinical evidence is more variable and depends heavily on the device, dose parameters, and application. Treating mechanistic and clinical evidence as the same leads to both overclaiming and unfair dismissal.
Where is the clinical evidence strongest?
Skin-related applications and wound healing are among the more studied areas, but results should not be generalized to every device or indication. Avci et al. (2013) summarized studies of skin responses, including collagen-related and repair outcomes, under specific wavelengths and exposure conditions. Muscle-performance and recovery studies include positive findings, but systematic reviews also report heterogeneity and limitations. Cognitive and mood applications are earlier-stage and require stronger evidence before firm conclusions are drawn.
Why don't doctors recommend red light therapy more often?
The gap between research and mainstream medical adoption has several causes. Devices use different output and measurement standards, so one study may be difficult to reproduce with another device. Limited physician familiarity and inconsistent dosimetry can also slow clinical translation. Heiskanen and Hamblin (2018) noted that LEDs and lasers have different beam and dosimetry characteristics, although both can be used in PBM research when properly specified.
Institutional sources must be read by exact indication and light type. Mayo Clinic's psoriasis guidance discusses controlled UVB and other light-therapy options; it should not be presented as a blanket endorsement of red light therapy for psoriasis, acne, or wound healing. FDA records show that some specific LED devices have clearance for specific labeled uses, but that clearance cannot be generalized to all red light therapy products.
The variables that determine whether a device delivers what the research describes
Professional red light therapy panel with labeled LED array, irradiance measurement point, wavelength output, and cooling fans
161 mW/cm² at 6 inches — a useful measurement only when its test conditions are fully documented.
Peer-reviewed studies used devices with measurable output parameters, but those parameters vary widely. The main question is whether a device documents comparable conditions in actual use. A single number is not enough. Wavelength bandwidth, measurement method, treatment area, uniformity, exposure time, pulsing, distance, and uncertainty also matter.
Irradiance at distance is an important measurement. Irradiance, measured in mW/cm², changes with distance and beam geometry. Marketing specifications may report peak values at very close distances. A claimed value such as 161 mW/cm² at 6 inches is useful only when the report gives the measurement distance, detector plane, spectral band, operating mode, warm-up time, sampling grid, and uncertainty. Do not describe 20–30 mW/cm² as universally ineffective. PBM studies use different parameters, and no single clinical threshold applies to every indication. IEC 62471:2006 addresses photobiological hazards through exposure limits, reference measurement methods, and risk-group classification. It is not a clinical efficacy standard.
Wavelength accuracy is another important variable. A device emitting at 680 nm rather than 660 nm, or at 880 nm rather than 850 nm, has a different spectral output. Tissue penetration and absorption also depend on tissue, geometry, and measurement conditions. Nominal wavelength alone does not prove a clinical effect. Request a traceable spectral test report and confirm whether the listed value is a peak wavelength, center wavelength, or nominal label. FDA registration, FCC/RoHS documentation, and CE marking should not be presented as proof of clinical efficacy.
Thermal management helps determine whether output remains stable during operation and aging. Temperature can affect LED output, spectral characteristics, component stress, and service life. A device that performs well when new may not maintain the same output after months of use if thermal design is inadequate. A 50,000-hour LED lifespan rating does not prove that the complete device will maintain its claimed irradiance. Request thermal-stability, aging, and output-retest data under defined conditions.
How to verify a device is built to deliver therapeutic output — not just therapeutic promises
Documented professional red light panel beside a generic consumer device
The gap between a device with documented research-relevant output and one that only looks convincing is often a measurement, documentation, or manufacturing problem. The research area is real. The question is whether a specific device can reproduce relevant conditions reliably.
Start by separating a manufacturer's declaration, a conformity assessment, and a product safety certification. CE marking is a manufacturer's declaration of conformity with applicable EU requirements. It is not a universal clinical-efficacy mark, and the assessment route depends on the product and risk class. An ETL listing may show certification to applicable safety standards when it is traceable. ISO 13485:2016 concerns an organization's medical-device quality-management system, not the clinical effectiveness of every product. Check all documents against the exact model and intended use.
What regulatory status tells you — and what it does not — is important. FDA establishment registration and device listing are regulatory records. The FDA states that registration or listing does not mean FDA approval, clearance, authorization, certification, safety evaluation, or effectiveness evaluation. For a device that requires premarket review, verify the relevant 510(k), De Novo, or PMA status for the exact model and intended use. "FDA registered" should never be used as a blanket efficacy claim.
Multi-market medical-device status can involve different legal roles, classifications, evidence requirements, and post-market obligations. Do not infer product status from an identifier alone. Verify the sponsor, manufacturer, model, classification, intended use, and current record in the relevant official database. Registrations and licences may support market access, but they do not automatically prove better quality or clinical effectiveness. For ETL, ISO 13485, or MDSAP claims, check the certificate holder, scope, model coverage, validity, and issuing organization.
Manufacturing consistency connects research results with real-world use. Clinical studies control device output at every session. Home users depend on the manufacturer's process controls to keep output consistent over time. REDDOT LED has a 37-step quality-inspection process, a 10,000 m² production facility, and market coverage in more than 80 countries. For product-level evaluation, ask suppliers for third-party test reports and registration documents. Check them against the exact model, test conditions, intended use, and production scope.
What the evidence supports, what it does not, and what that means for you
Person using a full-body red light therapy panel at home in a calm wellness room setting
Common belief: Red light therapy either works for everything or it's a complete scam — and the answer depends on which review you read last.
What's actually true: The research area is real, the evidence is stronger for some applications than others, and differences between research devices and consumer products are one reason study results do not automatically transfer to consumer outcomes.
For skin-related outcomes, wound healing, and some muscle-recovery questions, the clinical literature is worth reviewing. However, evidence strength differs by indication and protocol. Results from one device or study should not be generalized to every product. This is different from broad systemic claims supported only by animal data or from single-session "cure" claims.
Common belief: If a product is safe, it must also be effective.
What's actually true: Safety and efficacy are evaluated separately. Passing a photobiological-safety assessment does not prove therapeutic benefit. IEC 62471:2006 provides exposure limits, measurement methods, and risk-group classifications for optical-radiation hazards. The result depends on the measured device and exposure conditions; it is not a universal guarantee for every user. Safety documents also do not show whether a device matches the wavelength, irradiance, and exposure time used in a clinical study.
This leads to a more useful question. Instead of asking "does infrared and red light therapy really work?" in general, ask whether a specific device delivers the wavelengths and irradiance used in relevant research and whether that output has been independently verified. Form factors also matter. A full-body mat has different coverage and distance considerations from a flat panel. Evaluate each device using its documented performance, not the reputation of the product category.
Treat single-session claims, unverified specifications, and products with no traceable documentation with skepticism. Evidence for photobiomodulation is stronger in some areas and uncertain in others, so exaggeration is unnecessary. A well-specified device with clearly documented output is more consistent with reproducible research.
Key Takeaways
Red light therapy is studied through proposed pathways involving wavelengths such as 660 nm and 850 nm, mitochondrial chromophores including cytochrome c oxidase, and downstream cellular signaling. ATP-related, redox, circulation, and repair findings depend on the conditions and do not automatically predict a clinical outcome. In practice, documented wavelength, irradiance at a stated distance, exposure conditions, safety information, and indication-specific evidence matter more than the brand name.
FAQ
Why don't doctors recommend red light therapy?
Most physicians are cautious because photobiomodulation evidence and device specifications vary by indication. Medical education and clinical practice also differ between specialties. Some LED devices have received FDA 510(k) clearance for specific labeled uses, including certain wrinkle, acne, or temporary pain-related indications. That status cannot be generalized to all red light therapy products or uses.
What does Mayo Clinic say about red light therapy?
Check Mayo Clinic's exact wording and indication before citing it. Its psoriasis guidance discusses controlled light therapy such as UVB. This is not the same as endorsing red light therapy for psoriasis. Do not attribute recommendations for acne, psoriasis, or wound healing to Mayo unless a current Mayo page explicitly states them. Evaluate evidence and safety by the specific device, wavelength, exposure, and indication.
Does red light therapy work on a 70 year old woman?
Age alone does not determine whether red light therapy is appropriate or effective. The answer depends on the indication, device, exposure conditions, health status, medications, and outcome being measured. Older adults should follow the device instructions and seek professional advice when they have eye disease, photosensitivity, photosensitizing medication, an implanted device, or another relevant medical concern.
What's the downside of red light therapy?
The main downside is inconsistency. Results depend on the indication, device quality, exposure conditions, and whether the device delivers its claimed irradiance at a usable distance. Do not stare into a bright LED array. Use eye protection when required by the manufacturer, and seek professional advice if you have an eye condition or increased photosensitivity. Some studies use repeated exposures, but no universal timeline should be promised.
References
- FDA. "Laser Products and Instruments." U.S. Food & Drug Administration. https://www.fda.gov/radiation-emitting-products/home-business-and-entertainment-products/laser-products-and-instruments
- Hamblin, M.R. "Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation." Photochemistry and Photobiology, 2018. (PubMed PMID 29164625: https://pubmed.ncbi.nlm.nih.gov/29164625/)
- Heiskanen, V. and Hamblin, M.R. "Photobiomodulation: lasers vs. light emitting diodes?" Photochemical & Photobiological Sciences, 2018. (PubMed PMID 30044464: https://pubmed.ncbi.nlm.nih.gov/30044464/)
- Zein, R., Selting, W., and Hamblin, M.R. "Review of light parameters and photobiomodulation efficacy: dive into complexity." Journal of Biomedical Optics, 2018. (PubMed PMID 30550048: https://pubmed.ncbi.nlm.nih.gov/30550048/)
- ISO. "ISO 13485:2016 — Medical devices — Quality management systems — Requirements for regulatory purposes." https://www.iso.org/standard/59752.html
- Avci, P. et al. "Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring." Seminars in Cutaneous Medicine and Surgery, 2013. (PubMed PMID 24049929: https://pubmed.ncbi.nlm.nih.gov/24049929/)
- Ferraresi, C., Hamblin, M.R., and Parizotto, N.A. "Low-level laser (light) therapy (LLLT) on muscle tissue: performance, fatigue and repair benefited by the power of light." Photonics & Lasers in Medicine, 2012. (PubMed PMID 23626925: https://pubmed.ncbi.nlm.nih.gov/23626925/)
- Nampo, F.K. et al. "Effect of low-level phototherapy on delayed onset muscle soreness: a systematic review and meta-analysis." Lasers in Medical Science, 2016. (PubMed PMID 26563953: https://pubmed.ncbi.nlm.nih.gov/26563953/)
- FDA. "Important Reminders about Registration and Listing." https://www.fda.gov/medical-devices/device-registration-and-listing/important-reminders-about-registration-and-listing
- FDA. "510(k) Premarket Notification: K243978 — LED Facial Mask." https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K243978
- International Electrotechnical Commission. "IEC 62471:2006 — Photobiological safety of lamps and lamp systems." https://webstore.iec.ch/en/publication/7076
- Mayo Clinic. "Psoriasis — Diagnosis and treatment: Light therapy." https://www.mayoclinic.org/diseases-conditions/psoriasis/diagnosis-treatment/drc-20355845